Evidence map›Paper›PMID 39202590›Full record

Observational studyMedicina (Kaunas, Lithuania)2024

Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular-Kidney-Metabolic Factors: SIMETAP-AF Study.

Antonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, Ezequiel Arranz-Martínez, Vicente Pallarés-Carratalá

Abstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Age-Stratified Mortality Impact of Atrial Fibrillation in Elderly NSTEMI Patients.Journal of cardiovascular development and disease · 2026
    Article
  4. Metabolic and Inflammatory Mechanisms Driving Atrial Fibrillation.Annual review of pharmacology and toxicology · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Antonio Ruiz-GarcíaLipids and Cardiovascular Prevention Unit, Pinto University Health Centre, 28320 Madrid, Spain.ORCID 0000-0002-7902-5504
Adalberto Serrano-CumplidoRepelega Health Centre, 48920 Bizkaia, Spain.ORCID 0000-0001-7355-423X
Carlos Escobar-CervantesDepartment of Cardiology, La Paz University Hospital, 28046 Madrid, Spain.ORCID 0000-0001-5584-4735
Ezequiel Arranz-MartínezSan Blas Health Centre, 28981 Madrid, Spain.ORCID 0000-0003-0456-3444
Vicente Pallarés-CarrataláDepartment of Medicine, Jaume I University, 12006 Castellon, Spain.ORCID 0000-0002-2985-6078

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atrial FibrillationAdolescentAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansHypertensionMaleMiddle AgedPrevalenceRenal Insufficiency, ChronicRisk FactorsYoung Adultadultsatrial fibrillationchronic kidney diseaseheart failurehypertensionprevalencerisk factorsstroke

Identifiers

PMID39202590
PMCPMC11356659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.